CDK4 and breast carcinoma: Okada et al. provided a novel antitumor strategy of combining CDK4 inhibitor with autophagy inhibition by either chloroquine (CQ) or knockdown of ATG5 or BECN1 to induce synthetic lethal toxicity for BT474, MDA-MB435S, SKBr3 breast cancer cells 43.